News
Learn more about whether Penumbra, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor grades, ...
When these teams last met on Feb. 25, Dončić posted a 19-point, 15-rebound, 12-assist triple-double with three steals and two ...
Doctors explain everything you need to know about Lyme disease and what to do if you find a tick attached to your skin.
9h
FantasyPros on MSNNBA DFS Picks & Lineup Advice: Wednesday (4/9)Tonight’s massive 10-game NBA DFS slate comes on the final Wednesday of the regular season, bringing a mix of opportunity and ...
The Trump administration has pressed forwards with plans to unleash a wave of trillions in public spending cuts ...
J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...
The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...
1d
Medical Device Network on MSNShockwave begins study of IVL catheter for coronary artery lesions"Shockwave begins study of IVL catheter for coronary artery lesions" was originally created and published by Medical Device ...
Malaria parasites undergo a rapid and extensive metamorphosis after invasion of the host erythrocyte
Malaria parasites undergo an extensive metamorphosis after invasion of erythrocytes. This induces an increase in the surface ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared ...
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved an indication extension of DARZALEX® (daratumumab) subcutaneous (SC) ...
In the case of serious withdrawal, intravenous benzodiazepines can be ... among the oral agents in that its site of action is the peripheral muscle rather than the central neurotransmitter systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results